© Reuters. Pfizer’s logo is reflected in a drop on a syringe needle in this illustration
BERLIN (Reuters) – German Health Minister Jens Spahn expects a final purchase agreement with BioNTech (O:) and its partner Pfizer (N:) to be signed “in the coming days” for its potential vaccine against COVID-19.
“We will now bring this to a speedy conclusion,” Spahn told a news conference in Berlin.
Spahn said he expects Germany will get up to 100 million doses of the BioNTech-Pfizer vaccine.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.